Literature DB >> 12530000

Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer.

Yoshinori Ishida1, Kazuyuki Kawakami, Yoko Tanaka, Eiji Kanehira, Kenji Omura, Go Watanabe.   

Abstract

Thymidylate synthase (TS) is a target enzyme of 5-fluorouracil (5-FU). TS has a polymorphic repeated sequence in the 5'-UTR and the polymorphism is associated with TS protein expression. TS polymorphism has been reported to link with the efficacy of 5-FU-based chemotherapy in colorectal cancer. In this study, we examined whether the association among TS polymorphism, TS mRNA expression and TS protein expression is also observed in gastric cancer tissues and whether the TS polymorphism is a prognostic factor for patients with gastric cancer. We quantified TS mRNA isolated from 115 gastric cancer tissues by real-time reverse transcription PCR and TS protein in 72 available samples by the fluoro-dUMP binding assay. These values were compared with TS genotypes of the samples determined by a PCR assay. The tumor with the 3R/3R genotype had higher TS protein expression than that with the 2R/3R genotype, although there is no association between the TS genotype and mRNA expression. The result suggests that mRNA translation is responsible for the genotype-dependent difference of TS protein expression, as is consistent with our previous observation in colorectal cancer. This association encouraged us to further examine the link of the TS genotype with the stage of disease and the prognosis of the patients. The clinicopathological analysis showed that gastric cancers with the 3R/3R genotype are at a more advanced stage than those with the combined 2R/2R and 2R/3R genotype. We observed a longer survival in those patients with the combined 2R/2R and 2R/3R genotype, compared with the 3R/3R genotype, although it did not reach significance when the patients who had received the oral fluoropyrimidines therapy were analyzed. These results warrant further large-scale clinical study of the role of the TS genotyping for the prediction of efficacy using 5-FU-based chemotherapy and prognosis in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12530000

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions and gastric cancer.

Authors:  Wen Zhuang; Xiao-Ting Wu; Yong Zhou; Guan-Jian Liu; Tai-Xiang Wu; Xun Yao; Liang Du; Mao-Ling Wei
Journal:  Dig Dis Sci       Date:  2008-11-07       Impact factor: 3.199

2.  Influence of TS and ABCB1 gene polymorphisms on survival outcomes of 5‑FU-based chemotherapy in a Chinese population of advanced gastric cancer patients.

Authors:  Jun Chen; Xueming Ying; Ling Zhang; Xiaojun Xiang; Jianping Xiong
Journal:  Wien Klin Wochenschr       Date:  2017-01-10       Impact factor: 1.704

Review 3.  Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway.

Authors:  Wataru Ichikawa
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

4.  Expression of thymidylate synthase determines the response of gastric cancer patients undergoing gastrectomy to 5-fluorouracil-based adjuvant chemotherapy.

Authors:  Chun-Nan Yeh; Shih-Ming Jung; Tsung-Wen Chen; Tsann-Long Hwang; Yi-Yin Jan; Miin-Fu Chen
Journal:  Langenbecks Arch Surg       Date:  2009-12-10       Impact factor: 3.445

5.  Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy.

Authors:  Zhao-Hui Huang; Dong Hua; Li-Hua Li; Jing-De Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-21       Impact factor: 4.553

6.  Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer.

Authors:  Dong Hua; Zhao-Hui Huang; Yong Mao; Jian-Zhong Deng
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

Review 7.  Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review.

Authors:  Zhen Wang; Jun-qiang Chen; Jin-lu Liu; Xin-gan Qin; Yuan Huang
Journal:  BMC Gastroenterol       Date:  2012-09-29       Impact factor: 3.067

8.  UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy.

Authors:  E Martinez-Balibrea; A Abad; A Martínez-Cardús; A Ginés; M Valladares; M Navarro; E Aranda; E Marcuello; M Benavides; B Massutí; A Carrato; L Layos; J L Manzano; V Moreno
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

9.  Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients.

Authors:  E Goekkurt; S Hoehn; C Wolschke; C Wittmer; C Stueber; D K Hossfeld; J Stoehlmacher
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

10.  Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences.

Authors:  Hidekazu Kuramochi; Kazumi Uchida; Jeffery H Peters; Daisuke Shimizu; Daniel Vallbohmer; Sylke Schneider; Kathleen D Danenberg; Peter V Danenberg
Journal:  BMC Cancer       Date:  2009-05-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.